EP2261236
Samsetning til meltikornahindrunar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.12.2005EP published:
15.7.2015EP application number:
10179422.0
EP translation filed:
8.10.2015Grant published:
15.11.2015EPO information:
European Patent Register
Max expiry date:
6.12.2025Expiry date:
6.12.2025
Title:
Composition for proteasome inhibition
Timeline
Today
7.12.2005EP application
15.7.2015EP Publication
8.10.2015Translation submitted
15.11.2015Registration published
6.12.2025Expires
Owner
Name:
Onyx Therapeutics, Inc.Address:
249 East Grand Avenue, 94080, South San Francisco, CA, US
Inventor
Name:
Evan R. LewisAddress:
Pacifica, US
Name:
Mark NguyenAddress:
San Jose, US
Name:
Fabiana N. FonsecaAddress:
New York, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 38/14, C07K 5/087
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 12.4.2016
Expires: 6.12.2016
Payer: Árnason Faktor
Number: 12
Paid: 10.11.2016
Expires: 6.12.2017
Payer: Árnason Faktor
Number: 13
Paid: 9.11.2017
Expires: 6.12.2018
Payer: Árnason Faktor
Number: 14
Paid: 6.11.2018
Expires: 6.12.2019
Payer: Árnason Faktor
Number: 15
Paid: 7.11.2019
Expires: 6.12.2020
Payer: Árnason Faktor
Number: 16
Paid: 6.11.2020
Expires: 6.12.2021
Payer: Árnason Faktor ehf.
Number: 17
Paid: 8.11.2021
Expires: 6.12.2022
Payer: Árnason Faktor ehf.
Number: 18
Paid: 22.11.2022
Expires: 6.12.2023
Payer: Árnason Faktor ehf.
Number: 19
Paid: 11.12.2023
Expires: 6.12.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 22.11.2024
Expires: 6.12.2025
Payer: Árnason Faktor ehf.